Fifth vaccination with diphtheria, tetanus and acellular pertussis is beneficial in four- to six-year-olds
- 1 April 2001
- journal article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 20 (4) , 427-433
- https://doi.org/10.1097/00006454-200104000-00011
Abstract
Diphtheria, tetanus and pertussis serum antibody titers were assessed before a fifth dose of diphtheria-tetanus-acellular pertussis (DTaP) or diphtheria-tetanus-whole cell pertussis (DTwP) vaccination at age 4 to 6 years. Healthy children who had participated in a series of National Institutes of Health-sponsored trials assessing DTwP and DTaP vaccines provided prevaccination sera before a fifth dose of DTwP or DTaP. The trial design was prospective, randomized and double blind. Diphtheria, tetanus and pertussis antibody titers were measured by enzyme-linked immunosorbent assay. Pertussis results are expressed in enzyme-linked immunosorbent assay units/ml based on US Food and Drug Administration reference sera. Tetanus and diphtheria toxin concentrations are expressed in IU/ml with a WHO international reference sera as a standard. For diphtheria 100% of the children had antibody titers above the minimum protective level of 0.01 IU/ml and 86 to 100% (depending on prior vaccine product) had titers >0.1 IU/ml. However, only 0 to 40% of the children had antibody titers > or =1.0 IU/ml, a titer associated with more certain durable protection. For tetanus none of the children had an antibody titer below 0.01 IU/ml, and 93 to 100% had titers > or =0.1 IU/ml, a titer associated with more certain, durable protection. For pertussis the geometric mean concentrations of antibody before booster were uniformly very low, and the percentage of children exceeding the minimum detectable titer of antibody by 4-fold was also low. Before a 4- to 6-year-old booster, a large proportion of children have titers of antibody to diphtheria below the certain, durable protective level. Because serologic correlates and minimum protective titers of antibody to pertussis antigens have not been established, the relevance of the low titers determined in the current study is unknown but a potential concern.Keywords
This publication has 32 references indexed in Scilit:
- Correlation between Pertussis Toxin IgG Antibodies in Postvaccination Sera and Subsequent Protection against PertussisThe Journal of Infectious Diseases, 2000
- Immunogenicity of Tetanus‐Diphtheria Toxoids (Td) among Ukrainian Adults: Implications for Diphtheria Control in the Newly Independent States of the Former Soviet UnionThe Journal of Infectious Diseases, 2000
- KINETICS OF BOOSTER RESPONSES TO HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE AFTER COMBINED DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS-HAEMOPHILUS INFLUENZAE TYPE b VACCINATION IN INFANTSThe Pediatric Infectious Disease Journal, 1999
- Serum IgG Antibody Responses to Pertussis Toxin and Filamentous Hemagglutinin in Nonvaccinated and Vaccinated Children and Adults with PertussisClinical Infectious Diseases, 1999
- Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infantsThe Pediatric Infectious Disease Journal, 1997
- Diphtheria: Changing patterns in the developing world and the industrialized worldEuropean Journal of Epidemiology, 1995
- Parapertussis infection followed by pertussis infectionThe Lancet, 1994
- Serological correlates in whooping coughVaccine, 1993
- Estimation of Corynebacterium diphtheriae antitoxin in human sera: A comparison of an enzyme-linked immunosorbent assay with the toxin neutralisation testJournal of Medical Microbiology, 1988
- Antibody synthesis by bone marrow cells in vitro following primary and booster tetanus toxoid immunization in humans.Journal of Clinical Investigation, 1984